Elscint's flourishing position in MRI is doing wonders for themedical imaging vendor's top and bottom lines. Elscint realizedrevenues of $190.9 million in fiscal 1991 (end-December)--up from$161.9 million in 1990. The increase is based on an 85% growthin
Elscint's flourishing position in MRI is doing wonders for themedical imaging vendor's top and bottom lines. Elscint realizedrevenues of $190.9 million in fiscal 1991 (end-December)--up from$161.9 million in 1990. The increase is based on an 85% growthin revenues from its MRI product line, according to the company'sannual report.
The report signals the continuation of an impressive turnaroundfor the Haifa, Israel, corporation, which teetered at the brinkof bankruptcy in the late 1980s. Net income in 1991 grew to $17.1million, an increase of 27% over 1990.
Elscint held total assets of $171.7 million at year's end,with a debt-to-equity ratio of 15.6%. Working capital more thandoubled, to total $66.6 million.
Elscint's MRI division showed strong improvement, with dollarsales of MRI systems doubling in 1991. The company realized about$25 million in sales, up from $12.4 million the previous year.Sales of CT systems jumped 29%, to $53.9 million. Service incometotaled $53.4 million, a 5.4% increase from 1990.
Elscint's recent highlights include:
Elscint's North American operations made a substantial contributionto corporate performance. Revenues from North America rose byone-third, for a total of $74.5 million. Company officials creditedthe increase to the expansion of its U.S. marketing effort.
Breast MRI and Background Parenchymal Enhancement: What a Meta-Analysis Reveals
May 29th 2025Moderate or marked background parenchymal enhancement (BPE) reduces the sensitivity and specificity of MRI for breast cancer detection by more than 10 percent in comparison to scans with minimal or mild BPE, according to a new meta-analysis.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.